For more lab news and updates, please visit our Lab Blog!
Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract. J Am Acad Dermatol. 2014 May 17. (Click here to view)
KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation. J Clin Oncol. 2014 Mar 31. [Epub ahead of print]. (Click here to view)
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014 May 20;32(15):1563-70. (Click here to view)
Novel Mutations in Neuroendocrine Carcinoma of the Breast: Possible Therapeutic Targets. Diagn Mol Pathol. 2014 Feb 24. [Epub ahead of print]. (Click here to view)
Gastrointestinal stromal tumors: what do we know now? Mod Pathol. 2014 Jan;27 Suppl 1:S1-S16. (Click here to view)
Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin. J Clin Oncol. 2013 Jun 17. [Epub ahead of print]. (Click here to view)